MedPath

Assessing Effect of Withdrawal Time on Adenoma Detection Rate for Screening Colonoscopy

Not Applicable
Terminated
Conditions
Rectal Cancer
Colon Cancer
Colorectal Cancer
Registration Number
NCT05018325
Lead Sponsor
Washington University School of Medicine
Brief Summary

The investigators' null hypothesis is that a withdrawal time of 9 to 10 minutes is non-inferior to a withdrawal time of 12 minutes or greater. Thus, the goal of this tandem design trial is to compare the additional diagnostic yield (# of missed lesions) for withdrawal times exceeding 10 minutes for screening/surveillance colonoscopies. Although withdrawal times longer than the standard 6-minute recommendation have been shown to be beneficial, there is limited prospective evidence investigating the benefit or lack thereof for withdrawal times greater than 9-10 minutes.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
32
Inclusion Criteria
  • Must be between the ages of 18 and 75 years
  • Must be a patient undergoing screening or surveillance colonoscopy
  • Must be able to understand and willing to sign an IRB-approved written informed consent document.
Exclusion Criteria
  • Inability to provide informed consent.
  • Personal history of colorectal cancer (CRC)
  • Personal history of colon surgery or colon resection
  • Personal history of Inflammatory bowel disease
  • Personal history of familial polyposis
  • Current pregnancy
  • Active GI bleeding
  • Colonoscopy exams where the cecum cannot be reached (randomization will occur after cecum is reached).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Miss rate of polypsTime of colonoscopy (day 1)

* Miss rate = missed polyps/missed polyps + polyps found during 1st exam

* Polyps is defined as adenomas and sessile serrated adenomas (SSA)

Secondary Outcome Measures
NameTimeMethod
Miss rate of advanced adenomasTime of colonoscopy (day 1)

* Miss rate = missed advanced adenomas/missed advanced adenomas + advanced adenomas found during 1st exam

* Advanced adenoma defined as a polyp ≥ 10mm, adenomas with high-grade dysplasia or villous architecture, serrated lesions with dysplasia, or traditional serrated adenomas

Trial Locations

Locations (1)

Washington University School of Medicine

🇺🇸

Saint Louis, Missouri, United States

Washington University School of Medicine
🇺🇸Saint Louis, Missouri, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.